Check out your Company Bowl for anonymous work chats.
Movement towards the completion of our new home in Manchester Science Park continues as fit-out works begin and new CGI images reveal a first look at our future-ready, net zero lab and office space. Manchester’s position as a leading UK life sciences hub has taken a major step forward, as UK Biobank begins the fit-out of its new national headquarters at Bruntwood SciTech’s Greenheys – a purpose-built development at the heart of Manchester Science Park, due to complete in summer 2026. The relocation will also bring half of UK Biobank’s 350-strong team, cutting-edge robotics, and millions of biological samples donated by their altruistic volunteers to Greenheys. As well as accelerating research into diseases such as cancer, dementia, and heart disease, the relocation is expected to deliver significant economic value to the region and act as a catalyst for further growth across Greater Manchester’s science and innovation economy. Backed by £127.6 million of investment from UK Research and Innovation (UKRI), the move will support deeper collaboration between UK Biobank and Bruntwood SciTech’s regional partners, including The University of Manchester, Manchester Metropolitan University, and Manchester University NHS Foundation Trust (MFT).
Scanning 100,000 people isn’t just a milestone - it’s a massive team achievement ✅ From the initial invitation through to the first telephone call and the final scan, our admin, IT and mailing teams, contact centre, health research assistants, radiographers and training team have each played a vital role in this incredible achievement. You make every appointment count. And that's not to mention everyone involved in maximising participant response rates, those making data available to researchers and all of the teams keeping everything functioning behind the scenes. Thank you to everyone who has made this possible, Your hard work and dedication is helping to shape the future of health research.
🧠 An AI algorithm trained on data from 20,000 UK Biobank participants can spot early signs of Alzheimer's and Parkinson's disease. The new program has combined brain scans and activity-tracker data for the first time, in order to detect conditions at a very early stage - possibly before people even notice any symptoms. Anastasia Ilina, Imperial College London: "Studies like this push us forward towards adopting [AI prediction] in the near future, when we have a body of evidence that they can predict things early, help to diagnose early and can contribute to improvement of patient care."
Find out about more about UK Biobank news from May 2025
